Drugs / GM1 ganglioside
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00037830 Comparator | Nov 1999 → Jun 2010 | Parkinson disease | Thomas Jefferson University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GM1 ganglioside | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00037830 ↗ |
| Route | Subcutaneous | “100 mg twice per day by subcutaneous injection” NCT00037830 ↗ |